These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 370843)

  • 21. Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans.
    Larsson A; Fransson LA; Lewis WE
    Thromb Res; 1982 Jun; 26(6):401-9. PubMed ID: 7112518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interaction of human blood plasma proteins with glycosaminoglycans].
    Zorin NA
    Vopr Med Khim; 1983; 29(5):41-3. PubMed ID: 6417907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis.
    Karnovsky MJ; Wright TC; Castellot JJ; Choay J; Lormeau JC; Petitou M
    Ann N Y Acad Sci; 1989; 556():268-81. PubMed ID: 2525359
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of glycosaminoglycans (GAG) on the intramolecular bindings of collagen.
    Németh-Csóka M; Kovácsay A
    Acta Biol Acad Sci Hung; 1979; 30(4):303-8. PubMed ID: 162328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein: polyanion interactions. Studies on the trehalose-P synthetase as a model system.
    Elbein AD; Pan YT
    Adv Exp Med Biol; 1977; 86A():391-404. PubMed ID: 144431
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure and biological activity of heparin.
    Casu B
    Adv Carbohydr Chem Biochem; 1985; 43():51-134. PubMed ID: 3913287
    [No Abstract]   [Full Text] [Related]  

  • 27. Heparin binding peptides co-purify with glycosaminoglycans from human plasma.
    Chevanne M; Caldini R; Manao G; Ruggiero M; Vannucchi S
    FEBS Lett; 1999 Dec; 463(1-2):121-4. PubMed ID: 10601650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New data on heparin (a review)].
    Bychkov SM
    Vopr Med Khim; 1981; 27(6):726-36. PubMed ID: 7039095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of serum-induced proliferation of bovine tracheal smooth muscle cells in culture by heparin and related glycosaminoglycans.
    Kilfeather SA; Tagoe S; Perez AC; Okona-Mensa K; Matin R; Page CP
    Br J Pharmacol; 1995 Apr; 114(7):1442-6. PubMed ID: 7541692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemistry and pharmacology of heparin.
    Ehrlich J; Stivala SS
    J Pharm Sci; 1973 Apr; 62(4):517-44. PubMed ID: 4121531
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation and characterization of heparin from tuna skins.
    Jeske WP; McDonald MK; Hoppensteadt DA; Bau EC; Mendes A; Dietrich CP; Walenga JM; Coyne E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):137-45. PubMed ID: 17456622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.
    Majack RA; Clowes AW
    J Cell Physiol; 1984 Mar; 118(3):253-6. PubMed ID: 6699099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of a cyclic nucleotide-independent protein kinase (G-type casein kinase) by naturally occurring glycosaminoglycans.
    Feige JJ; Pirollet F; Cochet C; Chambaz EM
    FEBS Lett; 1980 Nov; 121(1):139-42. PubMed ID: 6161840
    [No Abstract]   [Full Text] [Related]  

  • 34. [Glycosaminoglycans: their structure and metabolism].
    Erzinkian KL; Trapkov VA
    Izv Akad Nauk SSSR Biol; 1988; (3):334-45. PubMed ID: 3045183
    [No Abstract]   [Full Text] [Related]  

  • 35. Heparin as inhibitor of mammalian protein synthesis. II. Degree of sulfation; related sulfated mucopolysaccharides.
    Waldman AA; Marx G; Goldstein J
    Biochim Biophys Acta; 1974 Apr; 343(2):324-9. PubMed ID: 4275930
    [No Abstract]   [Full Text] [Related]  

  • 36. Heparin.
    Jaques LB
    New Istanbul Contrib Clin Sci; 1973 Oct; 10(4):208-21. PubMed ID: 4132870
    [No Abstract]   [Full Text] [Related]  

  • 37. The release of platelet factor 4 (PF4) induced by heparin and related glycosaminoglycans (GAGs).
    Cella G; Scattolo N; Stevanato F; Girolami A
    Thromb Haemost; 1984 Aug; 52(1):94-5. PubMed ID: 6495270
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of heparin and related glycosaminoglycans (GAGs) on thrombin-induced platelet aggregation and release.
    Cofrancesco E; Colombi M; Manfreda M; Pogliani EM
    Haematologica; 1988; 73(6):471-5. PubMed ID: 3148509
    [No Abstract]   [Full Text] [Related]  

  • 39. Biologic actions of heparin.
    Rosenberg RD
    Semin Hematol; 1977 Oct; 14(4):427-40. PubMed ID: 144323
    [No Abstract]   [Full Text] [Related]  

  • 40. Different sensitivity of human red cell casein kinases towards glycoaminoglycans.
    Lecomte MC; Boivin P
    Biochem Biophys Res Commun; 1981 Sep; 102(1):420-5. PubMed ID: 6946772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.